# Tilt-table test

Intervention · id `cardio:tilt-table-test` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Tilt table test; Head-up tilt table test; Tilt-table testing

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Heart rhythm problems  

## In plain language

The tilt-table test is described in MeSH as a standard and widely accepted diagnostic test used to identify patients who have a vasodepressive and/or cardioinhibitory response as a cause of syncope. The introduction of a 2026 Cureus study (CC BY) says it is commonly used in clinical practice to evaluate patients with unexplained syncope, that it allows assessment of autonomic and cardiovascular responses to orthostatic stress, and that it plays a key role in distinguishing between syncope mechanisms such as orthostatic hypotension and vasovagal syncope. It adds that interpretation traditionally relies primarily on hemodynamic parameters, including blood pressure and heart rate changes. The sources read do not describe how the test is carried out, how accurate it is, or who should have it.

## Technical summary

MeSH D018667 (Tilt-Table Test, exact), last updated 2013-07-09. The scope note cites a textbook; only its first sentence is used. The Cureus article is a retrospective single-centre study of electrocardiographic and haemodynamic changes during tilt-table testing in patients with syncope; only the background statements in its introduction are used, not its results. No sensitivity, specificity, protocol, contraindication or risk is given by either source, so none is stated.

## Claims, with the population each applies to

## Context: People evaluated for syncope with a tilt-table test (MeSH scope note and a Cureus study introduction)

Recipient: Recipient not specified; Population: Patients who have a vasodepressive or cardioinhibitory response as a cause of syncope (MeSH) and patients with unexplained syncope (the Cureus introduction). Only background statements are used, not the study results.; Care setting: Not stated for the statements used; the Cureus study was done in a hospital in Kaunas, Lithuania.; Geography: Not stated. The sources read do not name a country.; Life stage: Not stated for the statements used; the Cureus study included adults aged 18 or older.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (a description of a symptom, condition or test).

### MeSH describes the tilt-table test as a standard and widely accepted diagnostic test used to identify patients who have a vasodepressive and/or cardioinhibitory response as a cause of syncope. The introduction of a 2026 Cureus study says tilt-table testing is commonly used in clinical practice to evaluate patients with unexplained syncope and plays a key role in distinguishing between syncope mechanisms such as orthostatic hypotension and vasovagal syncope.

- Category: Description
- Evidence stage: Evidence stage unknown
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients who have a vasodepressive or cardioinhibitory response as a cause of syncope (MeSH) and patients with unexplained syncope (the Cureus introduction). Only background statements are used, not the study results.; Care setting: Not stated for the statements used; the Cureus study was done in a hospital in Kaunas, Lithuania.; Geography: Not stated. The sources read do not name a country.; Life stage: Not stated for the statements used; the Cureus study included adults aged 18 or older.; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (a description of a symptom, condition or test).
- Limitations: A vocabulary scope note and background statements from the introduction of one study. Neither gives accuracy figures, a protocol, or who should have the test.
- Last checked: 2026-11-18
- Sources:
  1. Supports: MeSH scope note for descriptor D018667 (Tilt-Table Test) (Dataset, edition MeSH linked-data record of the preferred concept M0027971 of descriptor D018667, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0027971>
     Locator: scopeNote.@value, sentence 1. Retrieved 2026-11-18T23:57:20Z. Source state: Current. Version fingerprint: fcfbfe7c74d629844e917c8a41d680180850f1b620b57bc019ccb946f5d7aab4.
     How it applies: What the test is used to identify.
  2. Supports: Electrocardiographic and Hemodynamic Changes During Tilt-Table Testing in Patients With Syncope (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Cureus, published 4 May 2026), fetched 2026-11-18. A retrospective single-centre study. Used only for the background statements in its introduction (what syncope is and what tilt-table testing is used for); its results are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC13231248/>
     Locator: Introduction, para 1, sentence 3. Retrieved 2026-11-18T23:59:00Z. Source state: Current. Version fingerprint: c846fed244e9522b238cf0a5c96accc961e77cb57bdef778afe0ff773396a11b.
     How it applies: Commonly used to evaluate unexplained syncope.
  3. Supports: Electrocardiographic and Hemodynamic Changes During Tilt-Table Testing in Patients With Syncope (Publication, edition PMC Open Access subset full-text XML, from NCBI E-utilities (Cureus, published 4 May 2026), fetched 2026-11-18. A retrospective single-centre study. Used only for the background statements in its introduction (what syncope is and what tilt-table testing is used for); its results are not used.) <https://pmc.ncbi.nlm.nih.gov/articles/PMC13231248/>
     Locator: Introduction, para 1, sentence 4 (part). Retrieved 2026-11-18T23:59:00Z. Source state: Current. Version fingerprint: c846fed244e9522b238cf0a5c96accc961e77cb57bdef778afe0ff773396a11b.
     How it applies: Distinguishing syncope mechanisms such as orthostatic hypotension and vasovagal syncope.

## Connected pages

- Used to evaluate unexplained syncope: Fainting (syncope) (`cardio:fainting-syncope`) [a claim, not a settled fact; see claim `cardio:claim-tilt-table-syncope-evaluation` and its context]
- Helps distinguish orthostatic hypotension from other syncope mechanisms: Orthostatic hypotension (`cardio:orthostatic-hypotension`) [a claim, not a settled fact; see claim `cardio:claim-tilt-table-syncope-evaluation` and its context]
- Filed under this front: Diagnostics and imaging (`cardio:front-diagnostics-and-imaging`)
- Related to: Postural orthostatic tachycardia syndrome (POTS) (`cardio:postural-orthostatic-tachycardia-syndrome`)

## Provenance

Content hash: 6df0bf46e3dd4dc2effa1000dc20576a3c47711e664c53f40e9db3b6070752f4
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
